Publication: Health IT Answers
The article “AI in Life Sciences Finds an Early Success and Will Continue in 2025” explores the transformative impact of AI in life sciences, highlighting innovations across drug development, clinical trials, and personalized medicine. Fran Brown, SVP of Drug Development Solutions at Certara, emphasizes the growing use of AI-driven model-informed drug development techniques to refine first-in-human (FIH) dose predictions, reducing reliance on in vivo animal testing. The broader adoption of AI technologies promises enhanced accuracy, efficiency, and ethical advancements in drug development processes.
Published: 2024 年 12 月 24 日
Learn more about Quantitative Systems Pharmacology Consulting
Leverage Certara’s QSP team to answer questions about target prioritization, dose determination, assessing efficacy or toxicity, evaluating against competitors in the market, and more.
